Tracked deals
3
3 tracked deals across 2020-2021.
Morrisville, North Carolina, United States
Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. It translates clinical, commercial and real-world insights into outcomes to address modern market realities and speed delivery of important therapies to patients.
Tracked deals
3
3 tracked deals across 2020-2021.
Recent pace
0
0 tracked deals announced in the last 12 months.
Deal mix
Buyout
3 buyout
Last 2 years
Supporting Data
Elligo Health Research completed the acquisition of ClinEdge (including GuideStar Research and BTC of New Bedford) as part of a $135 million financing led by Morgan Stanley Expansion Capital and Ally Bridge Group, with participation from Norwest Venture Partners and existing investors. The deal expands Elligo’s global scale and capabilities by combining ClinEdge’s research practice management and clinical services with Elligo’s IntElligo technology, EHR-derived data access, and trial-acceleration platform.
Syneos Health acquired StudyKIK, a technology-enabled patient recruitment and retention company, from Kinderhook Industries. Financial terms were not disclosed; StudyKIK's platform (covering millions of patients and thousands of protocols/sites) will be integrated to expand Syneos' patient-focused, technology-enabled capabilities.
Syneos Health (NASDAQ: SYNH) has completed the acquisition of Synteract, a full-service contract research organization (CRO) focused on emerging biopharma. The seller was Amulet Capital Partners, which had previously built Synteract through organic investment and add-on acquisitions.
Turn tracked acquisition activity into an outreach-ready buyer list.